Edition:
United States

CareDx Inc (CDNA.OQ)

CDNA.OQ on NASDAQ Stock Exchange Global Market

26.21USD
19 Nov 2018
Change (% chg)

$-3.74 (-12.49%)
Prev Close
$29.95
Open
$29.81
Day's High
$30.00
Day's Low
$25.66
Volume
285,649
Avg. Vol
191,200
52-wk High
$30.11
52-wk Low
$4.92

Latest Key Developments (Source: Significant Developments)

CareDx Prices Public Offering Of 2 Mln Common Shares At $24.5/Shr
Tuesday, 13 Nov 2018 11:19pm EST 

Nov 13 (Reuters) - CareDx Inc ::CAREDX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 2.00 MILLION COMMON SHARES PRICED AT $24.50PER SHARE.  Full Article

CareDx Announces Proposed Public Offering Of Common Stock
Tuesday, 13 Nov 2018 04:01pm EST 

Nov 13 (Reuters) - CareDx Inc ::CAREDX ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.CAREDX INC - INTENDS TO OFFER AND SELL 2 MILLION SHARES OF ITS COMMON STOCK IN AN UNDERWRITTEN PUBLIC OFFERING.  Full Article

Caredx Inc Files For Mixed Shelf Offering Of Up To $200 Million
Friday, 31 Aug 2018 05:13pm EDT 

Aug 31 (Reuters) - CareDx Inc ::CAREDX INC FILES FOR MIXED SHELF OFFERING OF UP TO $200 MILLION.  Full Article

Olerup QTYPE Receives CE Mark Certification
Friday, 13 Apr 2018 08:00am EDT 

April 13 (Reuters) - Caredx Inc ::OLERUP QTYPE® RECEIVES CE MARK CERTIFICATION.OLERUP QTYPE RECEIVED CE MARK APPROVAL AND IS AVAILABLE ON BOTH ROCHE & APPLIED BIOSYSTEMS PLATFORMS.  Full Article

Caredx Launches Heartcare For Heart Transplant Recipients
Tuesday, 10 Apr 2018 08:00am EDT 

April 10 (Reuters) - CareDx Inc ::CAREDX LAUNCHES HEARTCARE® FOR HEART TRANSPLANT RECIPIENTS.ANNOUNCED LAUNCH OF HEARTCARE, A COMPREHENSIVE REJECTION SURVEILLANCE SOLUTION FOR HEART TRANSPLANT RECIPIENTS.  Full Article

CareDx Q4 Non-Gaap Loss Per Share $0.09
Thursday, 22 Mar 2018 04:01pm EDT 

March 22 (Reuters) - CareDx Inc ::CAREDX REPORTS FOURTH QUARTER AND FY2017 FINANCIAL RESULTS.Q4 NON-GAAP LOSS PER SHARE $0.09.Q4 LOSS PER SHARE $1.13.Q4 REVENUE $12.5 MILLION VERSUS I/B/E/S VIEW $12.3 MILLION.SEES FY 2018 REVENUE $61 MILLION TO $63 MILLION.FY2018 REVENUE VIEW $61.5 MILLION -- THOMSON REUTERS I/B/E/S.‍FOR FY 2018, CAREDX EXPECTS REVENUE TO BE IN RANGE OF $61 MILLION TO $63 MILLION, WITH PROFITABILITY EXPECTED DURING SECOND HALF OF YEAR​.  Full Article

Caredx - Entered Binding Commitment With Perceptive Advisors For Term Loan Of Between $15 Mln And $35 Mln
Thursday, 1 Mar 2018 07:30am EST 

March 1 (Reuters) - Caredx Inc ::CAREDX - ENTERED BINDING COMMITMENT WITH PERCEPTIVE ADVISORS FOR A TERM LOAN OF BETWEEN $15 MILLION AND $35 MILLION.CAREDX INC - NOTIFIED JGB OF CO'S INTENTION TO PREPAY OUTSTANDING PRINCIPAL BALANCE OF CONVERTIBLE NOTES ISSUED BY CO TO JGB.CAREDX - PERCEPTIVE ADVISORS TERM LOAN TO HAVE INTEREST RATE OF 10.5%, INTEREST-ONLY PERIOD OF 3 YEARS, MATURITY DATE OF APRIL 2023.CAREDX INC - UPON REPAYMENT TO JGB, $9.4 MILLION OF CO'S RESTRICTED CASH WILL BECOME AVAILABLE FOR USE.  Full Article

Caredx Sees FY 2017 Revenue $48.1 Mln To $48.3 Mln
Monday, 8 Jan 2018 08:30am EST 

Jan 8 (Reuters) - Caredx Inc ::CAREDX REPORTS PRELIMINARY FOURTH QUARTER AND FY2017 FINANCIAL RESULTS.SEES Q4 2017 REVENUE $12.3 MILLION TO $12.5 MILLION.SEES FY 2017 REVENUE $48.1 MILLION TO $48.3 MILLION.SEES Q4 2017 REVENUE UP 8 PERCENT.CAREDX - PRELIMINARY TOTAL CASH WAS $26.5 MILLION AS OF DEC 31, 2017.Q4 REVENUE VIEW $12.0 MILLION -- THOMSON REUTERS I/B/E/S.FY2017 REVENUE VIEW $47.9 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Caredx reports third quarter loss of $0.63 per share
Thursday, 9 Nov 2017 04:02pm EST 

Nov 9 (Reuters) - Caredx Inc :Caredx reports third quarter 2017 financial results.Q3 non-gaap loss per share $0.15.Q3 loss per share $0.63.Q3 revenue $12.2 million versus i/b/e/s view $12.1 million.Sees fy 2017 revenue $47 million to $49 million.  Full Article

CareDx closes public offering of common stock
Tuesday, 10 Oct 2017 04:00pm EDT 

Oct 10 (Reuters) - CareDx Inc :CareDx announces closing of public offering of common stock.  Full Article